^ Google the tail of the link: Neuren’s stock price doubles on groundbreaking drug trial.
- Forums
- ASX - By Stock
- NEU
- Neuren Media and Analyst Coverage
Neuren Media and Analyst Coverage, page-2
-
-
- There are more pages in this discussion • 1,115 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$19.64 |
Change
-0.300(1.50%) |
Mkt cap ! $2.548B |
Open | High | Low | Value | Volume |
$19.95 | $19.97 | $19.50 | $4.268M | 214.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 124 | $19.63 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.65 | 87 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 421 | 19.630 |
6 | 717 | 19.620 |
4 | 226 | 19.610 |
8 | 1155 | 19.600 |
6 | 796 | 19.590 |
Price($) | Vol. | No. |
---|---|---|
19.660 | 145 | 3 |
19.670 | 467 | 5 |
19.680 | 369 | 3 |
19.690 | 380 | 6 |
19.700 | 1253 | 5 |
Last trade - 12.10pm 20/06/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
INF
INFINITY LITHIUM CORPORATION LIMITED
Ryan Parkin, Managing Director & CEO
Ryan Parkin
Managing Director & CEO
Previous Video
Next Video
SPONSORED BY The Market Online